SCOTT DORFMAN

Concepts (100)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Societies, Medical
8
2020
693
0.430
Why?
Appendicitis
3
2019
126
0.260
Why?
Drowning
1
2024
41
0.230
Why?
Pneumonia
2
2020
323
0.210
Why?
Lung Injury
1
2024
124
0.210
Why?
Radiology
2
2020
106
0.190
Why?
Hydronephrosis
1
2020
35
0.180
Why?
Foot Injuries
1
2020
7
0.170
Why?
Near Drowning
1
2020
26
0.160
Why?
Radiography, Thoracic
1
2020
152
0.160
Why?
Hip Dislocation, Congenital
1
2019
18
0.160
Why?
Bone Diseases
1
2018
43
0.150
Why?
Evidence-Based Medicine
5
2020
635
0.150
Why?
Hematuria
1
2018
55
0.140
Why?
Peer Review, Health Care
1
2017
17
0.140
Why?
Medical Informatics Applications
1
2017
20
0.140
Why?
Leg
1
2018
158
0.140
Why?
Radiology Department, Hospital
1
2017
24
0.140
Why?
Movement Disorders
1
2018
222
0.130
Why?
Learning
1
2017
360
0.110
Why?
Diagnostic Imaging
3
2020
276
0.110
Why?
United States
8
2020
10887
0.110
Why?
Granuloma, Plasma Cell
1
2013
6
0.100
Why?
Bronchial Diseases
1
2013
12
0.100
Why?
Urinary Tract Infections
1
2017
302
0.100
Why?
Infant
8
2024
12468
0.100
Why?
Diagnosis, Differential
5
2019
1882
0.100
Why?
Quality Improvement
1
2017
639
0.090
Why?
Ultrasonography
4
2020
928
0.090
Why?
Infant, Newborn
6
2024
8189
0.090
Why?
Child
12
2024
24374
0.090
Why?
Contrast Media
3
2019
471
0.090
Why?
Infarction
2
2001
23
0.090
Why?
Omentum
2
2001
47
0.090
Why?
Child, Preschool
7
2024
14009
0.070
Why?
Acute Disease
4
2018
1110
0.070
Why?
Humans
18
2024
124593
0.060
Why?
Cross-Sectional Studies
2
2024
3424
0.050
Why?
Granulomatous Disease, Chronic
1
2004
66
0.050
Why?
Failure to Thrive
1
2004
90
0.050
Why?
Environmental Exposure
1
2004
220
0.050
Why?
Recurrence
2
2017
1420
0.050
Why?
Male
10
2024
61191
0.050
Why?
HIV-1
1
2004
465
0.040
Why?
Adolescent
4
2024
19279
0.040
Why?
Abdominal Pain
1
2001
310
0.040
Why?
Female
8
2024
66482
0.040
Why?
Cytarabine
2
1996
98
0.040
Why?
Radiology Information Systems
1
2017
23
0.040
Why?
Radionuclide Imaging
1
2017
149
0.030
Why?
Emergency Service, Hospital
1
2024
1087
0.030
Why?
Workflow
1
2017
117
0.030
Why?
Family
1
2020
562
0.030
Why?
Glomerulonephritis
1
2017
73
0.030
Why?
Renal Veins
1
1996
36
0.030
Why?
Vesico-Ureteral Reflux
1
2017
81
0.030
Why?
Leukocytosis
1
1996
46
0.030
Why?
Leukemia, Myeloid
1
1996
85
0.030
Why?
Epiglottitis
1
1995
12
0.030
Why?
Whole-Body Irradiation
1
1995
64
0.030
Why?
Enterobius
1
1995
1
0.030
Why?
Entamoeba histolytica
1
1995
14
0.030
Why?
Ascaris lumbricoides
1
1995
19
0.030
Why?
Trichuris
1
1995
26
0.030
Why?
Sensitivity and Specificity
1
2020
2050
0.030
Why?
Radiation Injuries
1
1995
142
0.030
Why?
Sex Factors
1
2017
1280
0.030
Why?
Kidney
2
2017
1358
0.030
Why?
Activin Receptors, Type II
1
2013
31
0.030
Why?
Bone Marrow Transplantation
1
1995
573
0.020
Why?
HIV Infections
1
2004
1892
0.020
Why?
Thrombosis
1
1996
519
0.020
Why?
Retrospective Studies
3
2024
16314
0.020
Why?
Gene Rearrangement
1
2013
320
0.020
Why?
Risk Factors
1
2024
10270
0.020
Why?
Leukocyte Count
2
2001
250
0.020
Why?
Prevalence
1
1995
2445
0.020
Why?
Pregnancy
1
2020
7179
0.020
Why?
Aged, 80 and over
1
1995
6533
0.010
Why?
NADPH Oxidases
1
2004
114
0.010
Why?
Tomography, X-Ray Computed
2
2004
2091
0.010
Why?
Phosphoproteins
1
2004
402
0.010
Why?
Body Temperature
1
2001
115
0.010
Why?
Appendectomy
1
2001
85
0.010
Why?
Diagnostic Errors
1
2001
332
0.010
Why?
Aged
1
1995
19703
0.010
Why?
Thioguanine
1
1996
21
0.010
Why?
Daunorubicin
1
1996
27
0.010
Why?
Leukapheresis
1
1996
13
0.010
Why?
Laparoscopy
1
2001
495
0.010
Why?
Atrophy
1
1996
228
0.010
Why?
Epiglottis
1
1995
9
0.010
Why?
Ultrasonography, Doppler
1
1996
195
0.010
Why?
Middle Aged
1
1995
26714
0.010
Why?
Adult
1
1995
29438
0.010
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
1995
129
0.010
Why?
Animals
1
1995
34072
0.010
Why?
Combined Modality Therapy
1
1995
1231
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1214
0.010
Why?
Prospective Studies
1
1999
6135
0.000
Why?
DORFMAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_